Results 51 to 60 of about 38,874 (189)
, 2017 This article answers the question: My patient carries a diagnosis of chronic anemia and has been treated for irondeficiency in the past with minimal to no improvement.
Coberly, Emily, Ringling, Rebecca
core
Cell and Gene Therapy in Equine Ocular Disease
Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.ABSTRACT Equine ocular disease is common and often challenging to treat using traditional methods. This has led to the development of new therapies. Like human medicine, veterinary medicine is adopting cellular and gene therapy as innovative approaches. Equine ocular disease is a particularly promising area for these techniques.
Kimberly A. S. Young +2 more
wiley +1 more source
Survival Probability in Patients with Sickle Cell Anemia Using the Competitive Risk Statistical Model. [PDF]
, 2019 The clinical picture of patients with sickle cell anemia (SCA) is associated with several complications some of which could be fatal. The objective of this study is to analyze the causes of death and the effect of sex and age on survival of Brazilian ...
Ballas, Samir K. +3 more
core +1 more source
Rare DMD Gene Duplication in a Lebanese Child With Duchene Muscular Dystrophy
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT A five‐year‐old boy with clinical features of Duchenne muscular dystrophy was found to have a rare de novo DMD exon 2–9 duplication. Reporting such atypical duplications improves genotype–phenotype interpretation and highlights the need for multidisciplinary care, particularly in resource‐limited settings.
Nada Assaf +4 more
wiley +1 more source
Molecular bases of α-thalassemia in Argentina [PDF]
, 2015 La α-talasemia, es uno de los desórdenes hereditarios más frecuentes mundialmente. Al presente, el diagnóstico molecular es la única herramienta que permite el diagnóstico certero.
Cerrone, Gloria Edith +5 more
core
A validated cellular biobank for β-thalassemia [PDF]
, 2016 Background: Cellular biobanking is a key resource for collaborative networks planning to use same cells in studies aimed at solving a variety of biological and biomedical issues. This approach is of great importance in studies on β-thalassemia, since the
BIANCHI, Nicoletta +15 more
core +2 more sources
Comprehensive Physiology, Volume 16, Issue 1, February 2026.Vildagliptin and omarigliptin, dipeptidyl peptidase‐4 (DPP‐4) inhibitors, have differential effects on bone cells. Although vildagliptin improved the bone microstructure of high‐fat diet‐fed rats, it was unable to downregulate osteoclastogenesis or the expression of key osteoclast transcripts.
Ratchaneevan Aeimlapa +11 more
wiley +1 more source
Pulmonary hypertension in adolescents with sickle cell disease [PDF]
, 2016 Sickle cell disease consists of a group of disorders that have a similar mutation in at least one of the beta-globin chains of hemoglobin. This results in a change of the hemoglobin to sickle shaped cells when in the deoxygenated state.
Akinyemi, Katherine
core +1 more source
Archipelago Method for Variant Set Association Test Statistics
Genetic Epidemiology, Volume 50, Issue 1, February 2026.ABSTRACT Variant set association tests (VSAT), especially those incorporating rare variants via variant collapse, are invaluable in genetic studies. However, unlike Manhattan plots for single‐variant tests, VSAT statistics lack intrinsic genomic coordinates, hindering visual interpretation.
Dylan Lawless +4 more
wiley +1 more source
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major [PDF]
, 2013 Transfusion and iron chelation treatment have significantly reduced morbidity and improved survival of patients with thalassemia major. However, cardiac disease continues to be the most common cause of death.
Barone, R +18 more
core +1 more source